You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Mallinckrodt
AstraZeneca
McKesson
Express Scripts

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Patent: 8,211,656

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,211,656
Title:Biological targeting compositions and methods of using the same
Abstract: Modified red blood cells are described. In an embodiment, the modified red blood cell includes a target-binding agent. Targeted delivery of imaging agents, drugs, and peptide and protein pharmaceuticals using modified red blood cells are described. Processes for preparing the modified red blood cells, pharmaceutical and diagnostic compositions containing the same and methods of diagnosis and treatment involving the modified red blood cells are described.
Inventor(s): Hyde; Roderick A. (Redmond, WA), Ishikawa; Muriel Y. (Livermore, CA), Jung; Edward K. Y. (Bellevue, WA), Gates; William (Redmond, WA), Langer; Alois A. (Harrison City, PA), Leuthardt; Eric C. (St. Louis, MO), Levien; Royce A. (Lexington, MA), Tegreene; Clarence T. (Bellevue, WA), Weaver; Thomas A. (San Mateo, CA), Whitmer; Charles (North Bend, WA), Wood, Jr.; Lowell L. (Bellevue, WA), Wood; Victoria Y. H. (Livermore, WA)
Assignee: The Invention Science Fund I, LLC (Bellevue, WA)
Application Number:12/228,880
Patent Claims:see list of patent claims

Details for Patent 8,211,656

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab SOLUTION;INTRAVENOUS 103705 001 1997-11-26   Start Trial The Invention Science Fund I, LLC (Bellevue, WA) 2039-02-26 RX search
Genentech RITUXAN rituximab SOLUTION;INTRAVENOUS 103705 002 1997-11-26   Start Trial The Invention Science Fund I, LLC (Bellevue, WA) 2039-02-26 RX search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25   Start Trial The Invention Science Fund I, LLC (Bellevue, WA) 2039-02-26 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
McKesson
Mallinckrodt
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.